Pennington, NJ, United States of America

Leena Fadnis

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leena Fadnis. Retrieved from https://idiyas.com/inventor/leena-fadnis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leena Fadnis: Innovator in Pharmaceutical Science

Introduction

Leena Fadnis is a prominent inventor based in Pennington, NJ (US). She has made significant contributions to the field of pharmaceutical science, particularly in the development of inhibitors for 15-lipoxygenase. Her work is crucial in addressing diseases related to the 15-LO cascade.

Latest Patents

Leena Fadnis holds 1 patent for her invention titled "Inhibitors of 15-lipoxygenase." This patent provides inhibitors of 15-LO according to Formula I, along with pharmaceutical compositions containing such inhibitors. The methods outlined in her patent are aimed at treating diseases associated with the 15-LO cascade using these compounds and compositions.

Career Highlights

Leena is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research and innovation in the pharmaceutical industry. Her expertise and dedication have positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Leena has collaborated with notable colleagues, including Natesan Murugesan and John E. Macor. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in pharmaceutical research.

Conclusion

Leena Fadnis exemplifies the spirit of innovation in the pharmaceutical industry through her groundbreaking work on 15-lipoxygenase inhibitors. Her contributions are vital for the advancement of treatments for related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…